Near-stoichiometric conversion of H(2)O(2) to Fe(IV)=O at a nonheme iron(II) center. Insights into the O-O bond cleavage step
- PMID: 20121136
- PMCID: PMC2823852
- DOI: 10.1021/ja9101908
Near-stoichiometric conversion of H(2)O(2) to Fe(IV)=O at a nonheme iron(II) center. Insights into the O-O bond cleavage step
Abstract
Near-quantitative formation of an oxoiron(IV) intermediate [Fe(IV)(O)(TMC)(CH(3)CN)](2+) (2) from stoichiometric H(2)O(2) was achieved with [Fe(II)(TMC)](2+) (1) (TMC = 1,4,8,11-tetramethyl-1,4,8,11-tetraaza-cyclotetradecane). This important outcome is best rationalized by invoking a direct reaction between 1 and H(2)O(2) followed by a heterolytic O-O bond cleavage facilitated by an acid-base catalyst (2,6-lutidine in our case). A sizable H/D KIE of 3.7 was observed for the formation of 2, emphasizing the importance of proton transfer in the cleavage step. Pyridines with different pK(a) values were also investigated, and less basic pyridines were found to function less effectively than 2,6-lutidine. This study demonstrates that the reaction of Fe(II) with H(2)O(2) to form Fe(IV)= O can be quite facile. Two factors promote the near-stoichiometric conversion of H(2)O(2) to Fe(IV)=O in this case: (a) the low reactivity between 1 and 2 and (b) the poor H-atom abstracting ability of 2, which inhibits subsequent reaction with residual H(2)O(2). Both factors inhibit formation of the Fe(III) byproduct commonly found in reactions of Fe(II) complexes with H(2)O(2). These results may shed light into the nature of the O-O bond cleaving step in the activation of dioxygen by nonheme iron enzymes and in the first step of the Fenton reaction.
Figures



Similar articles
-
Theoretical study of the mechanism of oxoiron(IV) formation from H2O2 and a nonheme iron(II) complex: O-O cleavage involving proton-coupled electron transfer.Inorg Chem. 2011 Jul 18;50(14):6637-48. doi: 10.1021/ic200522r. Epub 2011 Jun 16. Inorg Chem. 2011. PMID: 21678930 Free PMC article.
-
Dioxygen activation and catalytic aerobic oxidation by a mononuclear nonheme iron(II) complex.J Am Chem Soc. 2005 Mar 30;127(12):4178-9. doi: 10.1021/ja043083i. J Am Chem Soc. 2005. PMID: 15783193
-
Axial ligand effects on the geometric and electronic structures of nonheme oxoiron(IV) complexes.J Am Chem Soc. 2008 Sep 17;130(37):12394-407. doi: 10.1021/ja8022576. Epub 2008 Aug 20. J Am Chem Soc. 2008. PMID: 18712873 Free PMC article.
-
High-valent nonheme iron-oxo species in biomimetic oxidations.J Inorg Biochem. 2006 Apr;100(4):421-33. doi: 10.1016/j.jinorgbio.2006.01.014. Epub 2006 Mar 13. J Inorg Biochem. 2006. PMID: 16530841 Review.
-
Dioxygen activation at non-heme iron: insights from rapid kinetic studies.Acc Chem Res. 2007 Jul;40(7):510-21. doi: 10.1021/ar600041x. Epub 2007 May 24. Acc Chem Res. 2007. PMID: 17521158 Review.
Cited by
-
The biology and chemistry of high-valent iron-oxo and iron-nitrido complexes.Nat Commun. 2012 Mar 6;3:720. doi: 10.1038/ncomms1718. Nat Commun. 2012. PMID: 22395611 Review.
-
Coordination chemistry and reactivity of a cupric hydroperoxide species featuring a proximal H-bonding substituent.Inorg Chem. 2012 Dec 3;51(23):12603-5. doi: 10.1021/ic302071e. Epub 2012 Nov 15. Inorg Chem. 2012. PMID: 23153187 Free PMC article.
-
Heterolytic O-O Bond Cleavage Upon Single Electron Transfer to a Nonheme Fe(III)-OOH Complex.Chemistry. 2022 Sep 22;28(53):e202201600. doi: 10.1002/chem.202201600. Epub 2022 Aug 3. Chemistry. 2022. PMID: 35735122 Free PMC article.
-
Characterization of a high-spin non-heme Fe(III)-OOH intermediate and its quantitative conversion to an Fe(IV)═O complex.J Am Chem Soc. 2011 May 18;133(19):7256-9. doi: 10.1021/ja111742z. Epub 2011 Apr 25. J Am Chem Soc. 2011. PMID: 21517091 Free PMC article.
-
Iron-catalyzed asymmetric epoxidation of β,β-disubstituted enones.J Am Chem Soc. 2011 Jun 8;133(22):8432-5. doi: 10.1021/ja201873d. Epub 2011 May 16. J Am Chem Soc. 2011. PMID: 21553923 Free PMC article.
References
-
- Costas M, Mehn MP, Jensen MP, Que L., Jr Chem Rev. 2004;104:939–986. - PubMed
- Eser BE, Barr EW, Frantom PA, Saleh L, Bollinger JM, Jr, Krebs C, Fitzpatrick PF. J Am Chem Soc. 2007;129:11334–11335. - PMC - PubMed
- Chow MS, Eser BE, Wilson SA, Hodgson KO, Hedman B, Fitzpatrick PF, Solomon EI. J Am Chem Soc. 2009;131:7685–7698. - PMC - PubMed
- Schenk WA. Angew Chem Int Ed. 2000;39:3409–3411. - PubMed
- Brown-Marshall CD, Diebold AR, Solomon EI. Biochemistry. 2010 doi: 10.1021/bi901772w. Online Early Access. - DOI - PMC - PubMed
-
-
TMC = 1,4,8,11-tetramethyl-1,4,8,11-tetraazacyclotetradecane; TMC-Py = 1-(2-pyridylmethyl)-4,8,11-trimethyl-1,4,8,11-tetraazacyclotetradecane.
-
-
- Rohde JU, In JH, Lim MH, Brennessel WW, Bukowski MR, Stubna A, Münck E, Nam W, Que L., Jr Science. 2003;299:1037–1039. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources